ECSP10010626A - Derivados de iminopiridina y su uso - Google Patents

Derivados de iminopiridina y su uso

Info

Publication number
ECSP10010626A
ECSP10010626A EC2010010626A ECSP10010626A ECSP10010626A EC SP10010626 A ECSP10010626 A EC SP10010626A EC 2010010626 A EC2010010626 A EC 2010010626A EC SP10010626 A ECSP10010626 A EC SP10010626A EC SP10010626 A ECSP10010626 A EC SP10010626A
Authority
EC
Ecuador
Prior art keywords
iminopiridine
derivatives
present
compound
iminopyridine
Prior art date
Application number
EC2010010626A
Other languages
English (en)
Inventor
Masato Yoshida
Nobuki Sakauchi
Ayumu Sato
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of ECSP10010626A publication Critical patent/ECSP10010626A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invención pretende proporcionar un derivado de compuesto de iminopiridina que tiene una acción antagonista del receptor adrenérgico 1D, que es útil como un agente para la profilaxis o el tratamiento una enfermedad del tracto urinario inferior y similares. La presente invención provee un compuesto representado por la fórmula:en el cual cada símbolo es como se define en la memoria descriptiva, o una de sus sales.
EC2010010626A 2008-04-23 2010-11-23 Derivados de iminopiridina y su uso ECSP10010626A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008113135 2008-04-23

Publications (1)

Publication Number Publication Date
ECSP10010626A true ECSP10010626A (es) 2011-03-31

Family

ID=40821652

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010626A ECSP10010626A (es) 2008-04-23 2010-11-23 Derivados de iminopiridina y su uso

Country Status (24)

Country Link
US (2) US20090270393A1 (es)
EP (1) EP2271624B9 (es)
JP (1) JP5462803B2 (es)
KR (1) KR20100130235A (es)
CN (1) CN102066327B (es)
AR (1) AR071392A1 (es)
AU (1) AU2009238938A1 (es)
BR (1) BRPI0910737A2 (es)
CA (1) CA2723216C (es)
CL (1) CL2009000964A1 (es)
CO (1) CO6260091A2 (es)
CR (1) CR11765A (es)
DO (1) DOP2010000321A (es)
EA (1) EA019641B1 (es)
EC (1) ECSP10010626A (es)
ES (1) ES2478823T3 (es)
GE (1) GEP20135883B (es)
IL (1) IL208771A0 (es)
MX (1) MX2010011652A (es)
NZ (1) NZ588909A (es)
PE (1) PE20091784A1 (es)
TW (1) TW200948784A (es)
UY (1) UY31781A (es)
WO (1) WO2009131245A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470859B2 (en) * 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
PE20091784A1 (es) * 2008-04-23 2009-12-05 Takeda Pharmaceutical Derivados de iminopiridina con actividad sobre el receptor adrenergico alfa 1d
US9695118B2 (en) 2012-04-24 2017-07-04 Chugai Seiyaku Kabushiki Kaisha Benzamide derivative
KR20150003849A (ko) 2012-04-24 2015-01-09 추가이 세이야쿠 가부시키가이샤 퀴나졸린디온 유도체
CN103058913B (zh) * 2012-12-13 2015-09-30 江苏弘和药物研发有限公司 5-氯异吲哚酮的合成方法
KR20160073413A (ko) 2013-10-23 2016-06-24 추가이 세이야쿠 가부시키가이샤 퀴나졸리논 및 이소퀴놀리논 유도체
TW201609654A (zh) * 2014-05-28 2016-03-16 安斯泰來製藥股份有限公司 吡啶衍生物
CN111217731B (zh) * 2020-02-19 2022-06-03 广东工业大学 一种邻位亚胺酯或氰基取代的芳基硫醚衍生物及制备与应用
CN115703722B (zh) * 2021-08-03 2024-06-25 江苏国泰超威新材料有限公司 一种n,n-二甲基三氟甲基磺酰胺的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540109B1 (fr) * 1983-01-28 1985-08-30 Logeais Labor Jacques Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique
DE4021439A1 (de) * 1989-12-14 1991-06-20 Bayer Ag 2-iminopyridin-derivate
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
US6218396B1 (en) * 1998-02-20 2001-04-17 Orth-Mcneil Pharmaceutical, Inc. Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
US6153614A (en) * 1998-07-16 2000-11-28 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
DE19845202A1 (de) * 1998-10-01 2000-04-06 Wella Ag Haarwuchsmittel
ATE419239T1 (de) * 2000-10-20 2009-01-15 Eisai R&D Man Co Ltd Verfahren zur herstellung von 4-phenoxy chinolin derivaten
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
US7375100B2 (en) * 2003-06-04 2008-05-20 Pfizer Inc 2-amino-pyridine derivatives useful for the treatment of diseases
AU2005225632B2 (en) * 2004-03-23 2011-08-04 Pfizer Inc. Formamide derivatives useful as adrenoceptor
ES2241496B1 (es) * 2004-04-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridina.
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
TW200700392A (en) * 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
ES2303758B1 (es) * 2006-02-20 2009-08-13 Laboratorios Almirall S.A. Nuevos derivados de piridin-3-amina.
US8470859B2 (en) * 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8293747B2 (en) * 2007-07-19 2012-10-23 Merck Sharp & Dohme Corp. Heterocyclic amide compounds as protein kinase inhibitors
EA201001456A1 (ru) * 2008-03-21 2011-06-30 Новартис Аг Новые гетероциклические соединения и их применение
PE20091784A1 (es) * 2008-04-23 2009-12-05 Takeda Pharmaceutical Derivados de iminopiridina con actividad sobre el receptor adrenergico alfa 1d
US8290250B2 (en) * 2008-12-26 2012-10-16 Five Apes, Inc. Method and apparatus for creating a pattern recognizer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof

Also Published As

Publication number Publication date
EA019641B1 (ru) 2014-05-30
KR20100130235A (ko) 2010-12-10
US20110039846A1 (en) 2011-02-17
BRPI0910737A2 (pt) 2019-09-24
CN102066327A (zh) 2011-05-18
JP5462803B2 (ja) 2014-04-02
AU2009238938A1 (en) 2009-10-29
EP2271624A1 (en) 2011-01-12
NZ588909A (en) 2012-08-31
EP2271624B9 (en) 2014-11-12
CR11765A (es) 2010-12-15
CL2009000964A1 (es) 2010-03-26
MX2010011652A (es) 2010-12-06
TW200948784A (en) 2009-12-01
DOP2010000321A (es) 2010-11-15
WO2009131245A1 (en) 2009-10-29
GEP20135883B (en) 2013-07-25
PE20091784A1 (es) 2009-12-05
JP2011518766A (ja) 2011-06-30
ES2478823T3 (es) 2014-07-23
CN102066327B (zh) 2013-05-29
US20090270393A1 (en) 2009-10-29
CA2723216A1 (en) 2009-10-29
EP2271624B1 (en) 2014-05-21
CO6260091A2 (es) 2011-03-22
CA2723216C (en) 2017-01-24
AR071392A1 (es) 2010-06-16
EA201071229A1 (ru) 2011-06-30
IL208771A0 (en) 2010-12-30
UY31781A (es) 2009-12-14

Similar Documents

Publication Publication Date Title
ECSP10010626A (es) Derivados de iminopiridina y su uso
ECSP088210A (es) Bencimidazoles sustituidos y métodos de preparación
DOP2013000030A (es) Compuesto heterociclico y su uso
UY32923A (es) Compuestos policíclicos como antagonistas del receptor de ácido lisofosfatídico
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
CU20120071A7 (es) DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
ECSP12011573A (es) Compuestos tetracíclicos
CR20120448A (es) Compuesto heterocíclico
ECSP14013329A (es) Compuestos de arylcarbonil-4-oxy-piperidina utilizados para el tratamiento de enfermedades neurodegenerativas
ECSP13012719A (es) Compuesto bicíclico
DOP2010000267A (es) Compuesto heterociclico
CO6300955A2 (es) Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina -3
NI201000035A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3
CO6341625A2 (es) Derivados de indol como agentes anticáncer
DOP2009000287A (es) Oxazolidinonas sustituidas y su uso
CO6382123A2 (es) Antagonistas de la via hedgehog de ftalazina disustituida
CO6491037A2 (es) Derivados de pirazinooxazepina
ECSP088922A (es) Derivados de amino-tiazol y sus usos como agentes antibacterianos
CL2017000069A1 (es) Derivado de hidantoina.
CR20150148A (es) Azaindolinas
ECSP10010625A (es) Derivados de iminopiridina y uso de los mismos
ECSP088930A (es) Derivados de benzoxazol y benzotiazol como ligandos de
UY32191A (es) Derivados de iminopiridina y uso de los mismos
ECSP088789A (es) Derivados de sulfonil-3-heterociclilindazol como ligandos de 5-hidroxitriptamina-6